Literature DB >> 18206496

Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.

Nobuyuki Yanagisawa1, Rile Li, David Rowley, Hao Liu, Dov Kadmon, Brian J Miles, Thomas M Wheeler, Gustavo E Ayala.   

Abstract

We previously reported that reactive stromal grading in radical prostatectomies is a predictor of recurrence and that reactive stromal grading 0 and 3 are associated with lower biochemical recurrence-free survival rates than reactive stromal grading 1 and 2. We explored the prognostic significance of reactive stromal grading in preoperative needle biopsies. At Baylor College of Medicine, 224 cases of prostatic carcinoma were diagnosed by needle biopsy. Reactive stromal grading was evaluated on hematoxylin-eosin (H&E)-stained sections on the basis of previously described criteria: grade 0, with 0% to 5% reactive stroma; grade 1, 6% to 15%; grade 2, 16% to 50%; grade 3, 51% to 100%, or at least a 1:1 ratio between glands and stroma. Kaplan-Meier and Cox proportional hazard analyses were used. Reactive stromal grading distribution was as follows: reactive stromal grading 0, 1 case (0.5%); reactive stromal grading 1, 149 cases (66.5%); reactive stromal grading 2, 59 cases (26.3%); reactive stromal grading 3, 15 cases (6.7%). Reactive stromal grading in biopsies was correlated with adverse clinicopathologic parameters in the prostatectomy. Patients with reactive stromal grading 1 and 2 had better survival than those with 0 and 3 (P = .0034). Reactive stromal grading was an independent predictor of recurrence (hazard ratio = 1.953; P = .0174). Reactive stromal grading is independent of Gleason 4 + 3 and 3 + 4 in patients with a Gleason score of 7. Quantitation of reactive stroma and recognition of the stromogenic carcinoma in H&E-stained biopsies is useful to predict biochemical recurrence in prostate carcinoma patients independent of Gleason grade and prostate-specific antigen.

Entities:  

Year:  2008        PMID: 18206496     DOI: 10.1016/j.humpath.2007.04.025

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

Review 1.  Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.

Authors:  Takeshi Sasaki; Omar E Franco; Simon W Hayward
Journal:  Differentiation       Date:  2017-07-20       Impact factor: 3.880

2.  Biomarker identification with ligand-targeted nucleoprotein assemblies.

Authors:  Elizabeth M Singer; Laura E Crocitto; Yuri Choi; Sofia Loera; Lawrence M Weiss; S Ashraf Imam; Timothy G Wilson; Steven S Smith
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

3.  Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.

Authors:  J E Bohonowych; M W Hance; K D Nolan; M Defee; C H Parsons; J S Isaacs
Journal:  Prostate       Date:  2013-12-16       Impact factor: 4.104

Review 4.  Breast and prostate cancer: more similar than different.

Authors:  Gail P Risbridger; Ian D Davis; Stephen N Birrell; Wayne D Tilley
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

5.  Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.

Authors:  Gustavo E Ayala; Bahar Muezzinoglu; Kai H Hammerich; Anna Frolov; Hao Liu; Peter T Scardino; Rile Li; Mohammad Sayeeduddin; Michael M Ittmann; Dov Kadmon; Brian J Miles; Thomas M Wheeler; David R Rowley
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.

Authors:  Olga Dakhova; David Rowley; Michael Ittmann
Journal:  Clin Cancer Res       Date:  2013-10-22       Impact factor: 12.531

Review 7.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

8.  Global gene expression analysis of reactive stroma in prostate cancer.

Authors:  Olga Dakhova; Mustafa Ozen; Chad J Creighton; Rile Li; Gustavo Ayala; David Rowley; Michael Ittmann
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.

Authors:  Shumin Zhang; Xu Wang; Shareen Iqbal; Yanru Wang; Adeboye O Osunkoya; Zhengjia Chen; Zhuo Chen; Dong M Shin; Hongwei Yuan; Yongqiang A Wang; Haiyen E Zhau; Leland W K Chung; Chad Ritenour; Omer Kucuk; Daqing Wu
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

10.  The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts.

Authors:  A Shaw; J Gipp; W Bushman
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.